{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMED12 is an essential subunit of the evolutionarily conserved Mediator complex that physically links gene‐specific transcription factors to the RNA polymerase II initiation machinery. In doing so, it plays a key role in both activating and repressing transcription. For example, MED12 interacts with beta‐catenin to facilitate Wnt‐dependent target gene activation while also partnering with corepressor complexes (such as REST/G9a) to silence neuron‐specific genes in nonneuronal cells."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its bridging function, MED12 is central to modulating the activity of the Mediator kinase module. It acts as an allosteric activator of the CDK8 (and its paralog CDK19) kinase by enabling the proper assembly of Cyclin C–CDK complexes and positioning key activation elements. Structural and biochemical studies have revealed that MED12 wraps around CDK8/Cyclin C to promote kinase activation, and mutations in MED12 can disrupt this regulation, thereby affecting phosphorylation of diverse substrates involved in transcriptional control."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA prominent role for MED12 is revealed in benign uterine smooth muscle tumors—leiomyomas—in which highly recurrent somatic mutations (most commonly affecting exon 2) are found in a majority of cases. These mutations are thought to disturb the normal function of the Mediator complex and its kinase module, resulting in aberrant transcriptional programs that drive tumorigenesis. Large-scale sequencing studies across diverse patient populations have underscored the centrality of MED12 mutations in leiomyoma pathogenesis and their contribution to the clinical heterogeneity of these lesions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMED12 mutations are not confined to uterine leiomyomas; they have also been identified in a spectrum of other neoplasms. In breast fibroepithelial lesions (fibroadenomas and phyllodes tumors), leiomyosarcomas, certain thyroid tumors, and even in T-cell acute lymphoblastic leukemia, MED12 alterations have been implicated in oncogenesis. In several of these cancer types, aberrant MED12 function—sometimes via disruption of its ability to activate CDK8 kinase activity or through crosstalk with TGF-β signaling pathways—can contribute to drug resistance and aggressive tumor behavior, rendering MED12 a potential therapeutic target in these malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGermline as well as somatic mutations in MED12 also underlie several developmental disorders, including X‐linked intellectual disability syndromes such as Opitz–Kaveggia (FG) syndrome, Lujan syndrome, and forms of Ohdo syndrome. These mutations impair MED12’s capacity to fine tune gene expression during development, thereby contributing to craniofacial, neurodevelopmental, and behavioral abnormalities observed in affected individuals."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Seokjoong Kim, Xuan Xu, Andreas Hecht, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mediator is a transducer of Wnt/beta-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M602696200"}], "href": "https://doi.org/10.1074/jbc.M602696200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16565090"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16565090"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ning Ding, Haiying Zhou, Pierre-Olivier Esteve, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2008.05.023"}], "href": "https://doi.org/10.1016/j.molcel.2008.05.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18691967"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18691967"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Matthew T Knuesel, Krista D Meyer, Carrie Bernecky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.1767009"}], "href": "https://doi.org/10.1101/gad.1767009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19240132"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19240132"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Matthew T Knuesel, Krista D Meyer, Aaron J Donner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00993-08"}], "href": "https://doi.org/10.1128/MCB.00993-08"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19047373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19047373"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Mikko Turunen, Jason M Spaeth, Salla Keskitalo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2014.03.047"}], "href": "https://doi.org/10.1016/j.celrep.2014.03.047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24746821"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24746821"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Alison D Clark, Marieke Oldenbroek, Thomas G Boyer "}, {"type": "b", "children": [{"type": "t", "text": "Mediator kinase module and human tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Crit Rev Biochem Mol Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/10409238.2015.1064854"}], "href": "https://doi.org/10.3109/10409238.2015.1064854"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26182352"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26182352"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Wei-Wei Gao, Rong-Quan Xiao, Wen-Juan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2018.03.006"}], "href": "https://doi.org/10.1016/j.molcel.2018.03.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29628309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29628309"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Felix Klatt, Alexander Leitner, Iana V Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A precisely positioned MED12 activation helix stimulates CDK8 kinase activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1917635117"}], "href": "https://doi.org/10.1073/pnas.1917635117"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31988137"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31988137"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Netta Mäkinen, Miika Mehine, Jaana Tolvanen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1208930"}], "href": "https://doi.org/10.1126/science.1208930"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21868628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21868628"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Dominique Nadine Markowski, Sabine Bartnitzke, Thomas Löning, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.27424"}], "href": "https://doi.org/10.1002/ijc.27424"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22223266"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22223266"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Megan M McGuire, Alexander Yatsenko, Lori Hoffner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0033251"}], "href": "https://doi.org/10.1371/journal.pone.0033251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22428002"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22428002"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Eun Mi Je, Mee Ran Kim, Ki Ouk Min, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.27610"}], "href": "https://doi.org/10.1002/ijc.27610"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22532225"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22532225"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Elizabeth Bertsch, Wenan Qiang, Qing Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2013.243"}], "href": "https://doi.org/10.1038/modpathol.2013.243"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24390224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24390224"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Sabrina Croce, Frédéric Chibon "}, {"type": "b", "children": [{"type": "t", "text": "MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejca.2015.04.023"}], "href": "https://doi.org/10.1016/j.ejca.2015.04.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26037152"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26037152"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Hanna-Riikka Heinonen, Annukka Pasanen, Oskari Heikinheimo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-01199-0"}], "href": "https://doi.org/10.1038/s41598-017-01199-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28432313"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28432313"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Netta Mäkinen, Hanna-Riikka Heinonen, Shane Moore, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MED12 exon 2 mutations are common in uterine leiomyomas from South African patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.370"}], "href": "https://doi.org/10.18632/oncotarget.370"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22182697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22182697"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Gaëlle Pérot, Sabrina Croce, Agnès Ribeiro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MED12 alterations in both human benign and malignant uterine soft tissue tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0040015"}], "href": "https://doi.org/10.1371/journal.pone.0040015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22768200"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22768200"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "K Kämpjärvi, N Mäkinen, O Kilpivaara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2012.428"}], "href": "https://doi.org/10.1038/bjc.2012.428"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23132392"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23132392"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Sidong Huang, Michael Hölzel, Theo Knijnenburg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2012.10.035"}], "href": "https://doi.org/10.1016/j.cell.2012.10.035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23178117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23178117"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Weng Khong Lim, Choon Kiat Ong, Jing Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.3037"}], "href": "https://doi.org/10.1038/ng.3037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25038752"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25038752"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Andi K Cani, Daniel H Hovelson, Andrew S McDaniel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-14-0578"}], "href": "https://doi.org/10.1158/1541-7786.MCR-14-0578"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25593300"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25593300"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Nicole Pfarr, Mark Kriegsmann, Peter Sinn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.22256"}], "href": "https://doi.org/10.1002/gcc.22256"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25931199"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25931199"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Netta Mäkinen, Mervi Aavikko, Tuomas Heikkinen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1005850"}], "href": "https://doi.org/10.1371/journal.pgen.1005850"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26891131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26891131"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Tihana Ibrahimpasic, Bin Xu, Iñigo Landa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MED12"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "RBM10"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " as Novel Thyroid Cancer Genes Associated with Tumor Virulence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-17-1183"}], "href": "https://doi.org/10.1158/1078-0432.CCR-17-1183"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28634282"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28634282"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jean-François Spinella, Pauline Cassart, Chantal Richer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.11796"}], "href": "https://doi.org/10.18632/oncotarget.11796"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27602765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27602765"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Hiba Risheg, John M Graham, Robin D Clark, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng1992"}], "href": "https://doi.org/10.1038/ng1992"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17334363"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17334363"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Charles E Schwartz, Patrick S Tarpey, Herbert A Lubs, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.2006.048637"}], "href": "https://doi.org/10.1136/jmg.2006.048637"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17369503"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17369503"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Anneke T Vulto-van Silfhout, Bert B A de Vries, Bregje W M van Bon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in MED12 cause X-linked Ohdo syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2013.01.007"}], "href": "https://doi.org/10.1016/j.ajhg.2013.01.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23395478"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23395478"}]}]}]}